Analytical Data
-
基因名
GOLGA2
- Application
-
别名
130 kDa cis Golgi matrix protein; 130 kDa cis-Golgi matrix protein; Cis golgi matrix protein GM130; GM130; Gm130 autoantigen; GOGA2_HUMAN; GOLGA 2; Golga2; Golgi autoantigen; Golgi autoantigen golgin subfamily a 2; Golgi matrix protein GM130; Golgin 95
-
种属
Human
-
表达系统
E. coli
-
标签
GST-tag at N-terminal
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q08379
-
表达区间
1-345aa
-
氨基酸序列
MQNDRTTISRALSQNRELKEQLAELQSGFVKLTNENMEITSALQSEQHVKRELGKKLGELQEKLSELKETVELKSQEAQSLQQQRDQYLGHLQQYVAAYQQLTSEKEVLHNQLLLQTQLVDQLQQQEAQGKAVAEMARQELQETQERLEAATQQNQQLRAQLSLMAHPGEGDGLDREEEEDEEEEEEAVAVPQPMPSIPEDLESREAMVAFFNSAVASAEEEQARLRGQLKEQSVRCRRLAHLLASAQKEPEAAAPAPGTGGDSVCGETHRALQGAMEKLQSRFMELMQEKADLKERPGRVLPVTTPLHSRSCSCFVRCRTPGSAQAWAATPAFLFFTGLTRMMR
-
分子量
63.58 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Recombinant Mouse Arid5a Protein，His
Cat：PA2000-3825
Recombinant Human FABP12 Protein，His
Cat：PA1000-1071
Protein Description
GOLGA2, also known as GOLPH2 or GP73, is a Golgi apparatus-localized protein that has garnered interest in biomedical research due to its involvement in various cellular processes such as Golgi structure maintenance, protein trafficking, and glycosylation. Originally identified as a potential biomarker for liver diseases, GOLGA2 has shown elevated expression in liver cancer and viral hepatitis, raising its significance in oncological studies. Its role in the Golgi apparatus is crucial for the proper functioning of cellular secretion pathways, which makes it a valuable target for investigating secretory pathway dysregulation in cancer and other diseases. Furthermore, GOLGA2 has been implicated in the immune response and viral infections, suggesting its potential as a therapeutic target. The recombinant expression of GOLGA2 in model systems enables researchers to explore its biochemical properties, interaction networks, and functional consequences of its dysregulation. Understanding GOLGA2’s mechanisms of action could provide insights into its role in disease progression and contribute to the development of novel diagnostic and therapeutic strategies.
